Estimated Incidence of Symptomatic Lyme Borreliosis Cases in Lublin, Poland in 2021

Colby, Emily; Olsen, Julia; Angulo, Frederick J.; Kelly, Patrick; Halsby, Kate; Pilz, Andreas; Sot, Urszula; Chmielewski, Tomasz; Pancer, Katarzyna; Moïsi, Jennifer C.; Jodar, Luis; Stark, James H.

doi:10.3390/microorganisms11102481

Cited by 4 publications

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The lesions concern the musculoskeletal system, nervous system, and chronic skin lesions [ 5 , 6 ]. The non-specificity of the first symptoms and the occurrence of erythema only in some cases mean that the number of newly registered cases of Lyme disease is underestimated [ 7 ]. The number of new cases of Lyme disease has been steadily increasing since reporting began in 1996, and the number doubled between 2005 and 2015 [ 8 , 9 ].…”

Section: Backgrondmentioning

confidence: 99%

High Prevalence of Borrelia burgdorferi Antibodies in Jaworzno, Poland: A Retrospective Study Revealing Endemic Lyme Borreliosis

Koleżyńska,

Solarz,

Wieczorek

et al. 2023

Med Sci Monit

View full text Add to dashboard Cite

Background This retrospective study of 704 adult residents of Jaworzno, Poland, aimed to evaluate medical personnel awareness of episodes of Lyme borreliosis and serum antibody levels for Borrelia burgdorferi sensu lato. Material/Methods This study included 704 residents of Jaworzno, Poland, who had no more than 12 months between tick bite and screening. The study consisted of a self-designed questionnaire survey and an analysis of IgG and IgM antibodies against B . burgdorferi sensu lato using an enzyme-linked assay (ELISA) and Western blot analysis, when necessary, to confirm the results. Results A total of 558 residents (79.3%) confirmed having contact with a tick, 84 (11.9%) responded that they did not remember having contact with a tick, and 62 (8.8%) denied having contact with a tick. Regarding IgG, the ELISA showed 183 (25.99%) positive, 440 (62.5%) negative, and 81 (11.5%) equivocal results. Regarding IgM, the ELISA showed 180 (25.57%) positive, 435 (61.79%) negative, and 89 (12.64%) equivocal results. Positive and equivocal results for the IgG and IgM classes using the ELISA test were confirmed in 36 cases (13.64%) for IgG and in 53 cases (19.70%) for IgM using Western blot analysis. Conclusions The ELISA method obtained similar values for positive, negative, and equivocal results in the serological test. This was reflected in the survey conducted on residents who reported a tick bite and later received a positive result in the ELISA test as well as an approximate time between the bite and removal of the tick.

show abstract

Section: Backgrondmentioning

confidence: 99%

High Prevalence of Borrelia burgdorferi Antibodies in Jaworzno, Poland: A Retrospective Study Revealing Endemic Lyme Borreliosis

Koleżyńska,

Solarz,

Wieczorek

et al. 2023

Med Sci Monit

View full text Add to dashboard Cite

show abstract

Incidence of symptomatic Lyme borreliosis in nine European countries

Angulo,

Colby,

Lebech

et al. 2024

International Journal of Infectious Diseases

View full text Add to dashboard Cite

Estimated incidence of symptomatic Lyme borreliosis cases in five southern coastal counties in Norway, 2022

Colby,

Molden,

Olsen

et al. 2024

APMIS

View full text Add to dashboard Cite

Lyme borreliosis (LB), the most common tick‐borne disease in Europe, is endemic to southern coastal Norway. LB commonly presents as erythema migrans, which can disseminate, resulting in more severe disease such as Lyme neuroborreliosis or arthritis. In Norway, public health LB surveillance is conducted via mandatory reporting of laboratory‐confirmed disseminated cases. From 2012 to 2022, Norway's surveillance‐reported incidence of laboratory‐confirmed disseminated LB increased by 78%. Although surveillance provides estimates of the incidence of disseminated LB, this study sought to estimate the incidence of symptomatic LB to better understand Norway's LB disease burden. Two studies were identified that, when combined, estimated an LB seroprevalence of 6.8% in the general adult population in southern Norway. Utilizing data from these seroprevalence studies, public health surveillance, and results from literature searches indicating that 37% of seroconverted LB cases are symptomatic and that the duration of LB antibody detection ranges from 10 to 20 years, we estimated that there were 315–630 symptomatic LB cases per 100,000 adult population in five southern coastal counties in Norway in 2022 and 24–48 cases of symptomatic LB for every public health surveillance‐reported LB case in adults in these five counties in Norway.

show abstract

Estimated Incidence of Symptomatic Lyme Borreliosis Cases in Lublin, Poland in 2021

Cited by 4 publications

References 35 publications

High Prevalence of Borrelia burgdorferi Antibodies in Jaworzno, Poland: A Retrospective Study Revealing Endemic Lyme Borreliosis

High Prevalence of Borrelia burgdorferi Antibodies in Jaworzno, Poland: A Retrospective Study Revealing Endemic Lyme Borreliosis

Incidence of symptomatic Lyme borreliosis in nine European countries

Estimated incidence of symptomatic Lyme borreliosis cases in five southern coastal counties in Norway, 2022

Contact Info

Product

Resources

About